Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

A Prognostic Tool for Individualized Prediction of Graft Failure Risk within Ten Years after Kidney Transplantation.

Stamenic D, Rousseau A, Essig M, Gatault P, Buchler M, Filloux M, Marquet P, Prémaud A.

J Transplant. 2019 Apr 8;2019:7245142. doi: 10.1155/2019/7245142. eCollection 2019.

2.

The association between renal resistive index and premature mortality after kidney transplantation is modified by pre-transplant diabetes status: a cohort study.

de Freminville JB, Vernier LM, Roumy J, Patat F, Gatault P, Sautenet B, Bailly E, Chevallier E, Barbet C, Longuet H, Merieau E, Baron C, Buchler M, Halimi JM.

Nephrol Dial Transplant. 2019 Apr 26. pii: gfz067. doi: 10.1093/ndt/gfz067. [Epub ahead of print]

PMID:
31028403
3.

Increased risk of rejection after basiliximab induction in sensitized kidney transplant recipients without pre-existing donor-specific antibodies - a retrospective study.

Goumard A, Sautenet B, Bailly E, Miquelestorena-Standley E, Proust B, Longuet H, Binet L, Baron C, Halimi JM, Büchler M, Gatault P.

Transpl Int. 2019 Mar 23. doi: 10.1111/tri.13428. [Epub ahead of print]

PMID:
30903722
4.

Transplant center characteristics associated with living-donor kidney transplantation: a cohort study with a hierarchical modeling approach.

Châtelet V, Gatault P, Hazzan M, Anglicheau D, Launoy G, Lobbedez T, Moulin B.

Transpl Int. 2019 Mar 22. doi: 10.1111/tri.13429. [Epub ahead of print]

PMID:
30903630
5.

Evaluation of outcomes in renal transplantation with hypothermic machine perfusion for the preservation of kidneys from expanded criteria donors.

Savoye E, Macher MA, Videcoq M, Gatault P, Hazzan M, Abboud I, Thierry A, Bertrand D, Drouin S, Sayegh J, Barrou B, Badet L, Bastien O, Huot O, Lamotte C, Logerot H, Legeai C, Antoine C.

Clin Transplant. 2019 May;33(5):e13536. doi: 10.1111/ctr.13536. Epub 2019 Apr 10.

PMID:
30869162
6.

Etiology and Outcomes of Thrombotic Microangiopathies.

Bayer G, von Tokarski F, Thoreau B, Bauvois A, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Buchler M, Vigneau C, Fakhouri F, Halimi JM.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):557-566. doi: 10.2215/CJN.11470918. Epub 2019 Mar 12.

PMID:
30862697
7.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
8.

Impact on renal resistive index of diabetes in renal transplant donors and recipients: A retrospective analysis of 1827 kidney transplant recipients.

de Freminville JB, Vernier LM, Roumy J, Patat F, Gatault P, Sautenet B, Bailly E, Chevallier E, Barbet C, Longuet H, Merieau E, Baron C, Buchler M, Halimi JM.

J Clin Hypertens (Greenwich). 2019 Mar;21(3):382-389. doi: 10.1111/jch.13492. Epub 2019 Feb 14.

9.

CMV disease and colitis in a kidney transplanted patient under pembrolizumab.

Gueguen J, Bailly E, Machet L, Miquelestorena-Standley E, Stefic K, Gatault P, Büchler M.

Eur J Cancer. 2019 Mar;109:172-174. doi: 10.1016/j.ejca.2018.12.027. Epub 2019 Feb 4. No abstract available.

PMID:
30731278
10.

Renal function at the time of nephrology referral but not dialysis initiation as a risk for death in patients with diabetes mellitus.

Pinier C, Gatault P, François M, Barbet C, Longuet H, Rabot N, Noble J, Bailly E, Buchler M, Sautenet B, Halimi JM.

Clin Kidney J. 2018 Dec;11(6):762-768. doi: 10.1093/ckj/sfy032. Epub 2018 Jun 2.

11.

Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases.

Arrestier R, Satie AP, Zhang SY, Plaisier E, Isnard-Bagnis C, Gatault P, Raimbourg Q, Buob D, Vocila F, Heng AE, Francois H, Moktefi A, Canaud G, Matignon M, Dejucq-Rainsford N, Brocheriou I, Sahali D, Audard V.

BMC Nephrol. 2018 Nov 20;19(1):331. doi: 10.1186/s12882-018-1132-x.

12.

An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).

Rémy P, Audard V, Natella PA, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Ait Sahlia N, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D; MSN Trial Investigators.

Kidney Int. 2018 Dec;94(6):1217-1226. doi: 10.1016/j.kint.2018.07.021. Epub 2018 Oct 29.

PMID:
30385039
13.

[Human resources allocated to kidney transplantation in 2016 in France: A national survey].

Gatault P, Hazzan M, Anglicheau D, Moulin B; Commission transplantation de la SFNDT.

Nephrol Ther. 2018 Nov;14(6):491-498. doi: 10.1016/j.nephro.2018.06.002. Epub 2018 Aug 25. French.

PMID:
30154055
14.

The age-calibrated measured glomerular filtration rate improves living kidney donation selection process.

Gaillard F, Courbebaisse M, Kamar N, Rostaing L, Del Bello A, Girerd S, Kessler M, Flamant M, Vidal-Petiot E, Peraldi MN, Couzi L, Merville P, Malvezzi P, Janbon B, Moulin B, Caillard S, Gatault P, Büchler M, Maillard N, Dubourg L, Roquet O, Garrouste C, Legendre C, Delanaye P, Mariat C.

Kidney Int. 2018 Sep;94(3):616-624. doi: 10.1016/j.kint.2018.05.016.

PMID:
30143068
15.

No impact of disseminated intravascular coagulation in kidney donors on long-term kidney transplantation outcome: A multicenter propensity-matched study.

Garrouste C, Baudenon J, Gatault P, Pereira B, Etienne I, Thierry A, Szlavik N, Aniort J, Rabant M, Lambert C, Sayegh J, Oniszczuk J, Anglicheau D, Heng AE.

Am J Transplant. 2019 Feb;19(2):448-456. doi: 10.1111/ajt.15008. Epub 2018 Aug 23.

PMID:
29981217
16.

Progression of Mineral Ion Abnormalities in Patients With Jansen Metaphyseal Chondrodysplasia.

Saito H, Noda H, Gatault P, Bockenhauer D, Loke KY, Hiort O, Silve C, Sharwood E, Martin RM, Dillon MJ, Gillis D, Harris M, Rao SD, Pauli RM, Gardella TJ, Jüppner H.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2660-2669. doi: 10.1210/jc.2018-00332.

17.

A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen.

Woillard JB, Gatault P, Picard N, Arnion H, Anglicheau D, Marquet P.

Am J Transplant. 2018 Dec;18(12):2905-2913. doi: 10.1111/ajt.14894. Epub 2018 Jun 1.

PMID:
29689130
18.

CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells.

Gatault P, Al-Hajj S, Noble J, Chevallier E, Piollet M, Forconi C, Gaudy-Graffin C, Thibault G, Miquelestorena-Standley E, Halimi JM, Büchler M, Lemoine R, Baron C.

Am J Transplant. 2018 Aug;18(8):1904-1913. doi: 10.1111/ajt.14672. Epub 2018 Mar 3.

PMID:
29377506
19.

Predictive factors of spontaneous CMV DNAemia clearance in kidney transplantation.

Noble J, Gatault P, Sautenet B, Gaudy-Graffin C, Beby-Defaux A, Thierry A, Essig M, Halimi JM, Munteanu E, Alain S, Buchler M.

J Clin Virol. 2018 Feb - Mar;99-100:38-43. doi: 10.1016/j.jcv.2017.12.011. Epub 2017 Dec 29.

PMID:
29306112
20.

Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.

Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C, Gatault P, Buchler M, Charpentier B, Thervet E, Cassuto E.

Pharmacol Res. 2018 Mar;129:84-94. doi: 10.1016/j.phrs.2017.12.005. Epub 2017 Dec 8.

PMID:
29229354
21.

Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort.

Cognard N, Anglicheau D, Gatault P, Girerd S, Essig M, Hurault de Ligny B, Le Meur Y, Le Roy F, Garrouste C, Thierry A, Colosio C, Rivalan J, Sayegh J, Choukroun G, Moulin B, Caillard S.

Transplantation. 2018 May;102(5):860-867. doi: 10.1097/TP.0000000000002009.

PMID:
29215458
22.

Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.

Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M.

Transplantation. 2018 Apr;102(4):688-698. doi: 10.1097/TP.0000000000002002.

PMID:
29135832
23.

Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease.

Trivin C, Tran A, Moulin B, Choukroun G, Gatault P, Courivaud C, Augusto JF, Ficheux M, Vigneau C, Thervet E, Karras A.

Clin Kidney J. 2017 Aug;10(4):461-469. doi: 10.1093/ckj/sfw101. Epub 2016 Nov 10.

24.

Development and validation of an enzyme-linked immunosorbent assay to measure free eculizumab concentration in serum.

Passot C, Desvignes C, Ternant D, Bejan-Angoulvant T, Duveau AC, Gatault P, Paintaud G.

Bioanalysis. 2017 Aug;9(16):1227-1235. doi: 10.4155/bio-2017-0070. Epub 2017 Aug 2.

PMID:
28766381
25.

An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies.

Prémaud A, Filloux M, Gatault P, Thierry A, Büchler M, Munteanu E, Marquet P, Essig M, Rousseau A.

PLoS One. 2017 Jul 3;12(7):e0180236. doi: 10.1371/journal.pone.0180236. eCollection 2017.

26.

Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study.

Demiselle J, Auchabie J, Beloncle F, Gatault P, Grangé S, Du Cheyron D, Dellamonica J, Boyer S, Beauport DT, Piquilloud L, Letheulle J, Guitton C, Chudeau N, Geri G, Fourrier F, Robert R, Guérot E, Boisramé-Helms J, Galichon P, Dequin PF, Lautrette A, Bollaert PE, Meziani F, Guillevin L, Lerolle N, Augusto JF.

Ann Intensive Care. 2017 Dec;7(1):39. doi: 10.1186/s13613-017-0262-9. Epub 2017 Apr 5.

27.

PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.

Cornec-Le Gall E, Audrézet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, Frouget T, Vigneau C, Dantal J, Siohan P, Longuet H, Gatault P, Ecotière L, Bridoux F, Mandart L, Hanrotel-Saliou C, Stanescu C, Depraetre P, Gie S, Massad M, Kersalé A, Séret G, Augusto JF, Saliou P, Maestri S, Chen JM, Harris PC, Férec C, Le Meur Y.

Am J Kidney Dis. 2017 Oct;70(4):476-485. doi: 10.1053/j.ajkd.2017.01.046. Epub 2017 Mar 27.

28.

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.

Ishida JH, Patel A, Mehta AK, Gatault P, McBride JM, Burgess T, Derby MA, Snydman DR, Emu B, Feierbach B, Fouts AE, Maia M, Deng R, Rosenberger CM, Gennaro LA, Striano NS, Liao XC, Tavel JA.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01794-16. doi: 10.1128/AAC.01794-16. Print 2017 Feb.

29.

Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

Gatault P, Kamar N, Büchler M, Colosio C, Bertrand D, Durrbach A, Albano L, Rivalan J, Le Meur Y, Essig M, Bouvier N, Legendre C, Moulin B, Heng AE, Weestel PF, Sayegh J, Charpentier B, Rostaing L, Thervet E, Lebranchu Y.

Am J Transplant. 2017 May;17(5):1370-1379. doi: 10.1111/ajt.14109. Epub 2017 Jan 3.

30.

Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.

Forconi C, Gatault P, Miquelestorena-Standley E, Noble J, Al-Hajj S, Guillemain R, Stern M, Hoffmann T, Prat L, Suberbielle C, Masson E, Cesbron-Gautier A, Gaudy-Graffin C, Goudeau A, Thibault G, Ivanes F, Guibon R, Kazma I, Lebranchu Y, Büchler M, Magnan A, Halimi JM, Baron C.

J Heart Lung Transplant. 2017 Mar;36(3):315-324. doi: 10.1016/j.healun.2016.08.014. Epub 2016 Aug 26.

PMID:
27751774
31.

Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.

Garrouste C, Anglicheau D, Kamar N, Bachelier C, Rivalan J, Pereira B, Caillard S, Aniort J, Gatault P, Soubrier M, Sayegh J, Colosio C, Buisson A, Thervet E, Bouvier N, Heng AE.

Medicine (Baltimore). 2016 Oct;95(41):e5108.

32.

Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation.

Dupin C, Marchand-Adam S, Favelle O, Costes R, Gatault P, Diot P, Grammatico-Guillon L, Guilleminault L.

J Clin Immunol. 2016 Nov;36(8):810-817. Epub 2016 Oct 6.

PMID:
27714565
33.

What are the characteristics of asthma patients with elevated serum IgG4 levels?

Flament T, Marchand-Adam S, Gatault P, Dupin C, Diot P, Guilleminault L.

Respir Med. 2016 Mar;112:39-44. doi: 10.1016/j.rmed.2016.01.014. Epub 2016 Jan 22.

34.

The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients.

Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sørensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, Mühlfeld A, Orlando G, Clemente K, Lai Q, Pisani F, Kandus A, Baas M, Bemelman F, Ponikvar JB, Mazouz H, Stratta P, Subra JF, Villemain F, Hoitsma A, Braun L, Cantarell MC, Colak H, Courtney A, Frasca GM, Howse M, Naesens M, Reischig T, Serón D, Seyahi N, Tugmen C, Alonso Hernandez A, Beňa L, Biancone L, Cuna V, Díaz-Corte C, Dufay A, Gaasbeek A, Garnier A, Gatault P, Gentil Govantes MA, Glowacki F, Gross O, Hurault de Ligny B, Huynh-Do U, Janbon B, Jiménez Del Cerro LA, Keller F, La Manna G, Lauzurica R, Le Monies De Sagazan H, Thaiss F, Legendre C, Martin S, Moal MC, Noël C, Pillebout E, Piredda GB, Puga AR, Sulowicz W, Tuglular S, Prokopova M, Chesneau M, Le Moine A, Guérif P, Soulillou JP, Abramowicz M, Giral M, Racapé J, Maggiore U, Brouard S, Abramowicz D.

Nephrol Dial Transplant. 2016 Jun;31(6):1002-13. doi: 10.1093/ndt/gfv437. Epub 2016 Jan 12.

PMID:
26763669
35.

Community pharmacist intervention in patients with renal impairment.

Pourrat X, Sipert AS, Gatault P, Sautenet B, Hay N, Guinard F, Guegan F, Halimi JM.

Int J Clin Pharm. 2015 Dec;37(6):1172-9. doi: 10.1007/s11096-015-0182-4. Epub 2015 Sep 18.

PMID:
26385098
36.

Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule.

Gatault P, Brachet G, Ternant D, Degenne D, Récipon G, Barbet C, Gyan E, Gouilleux-Gruart V, Bordes C, Farrell A, Halimi JM, Watier H.

MAbs. 2015;7(6):1205-11. doi: 10.1080/19420862.2015.1086049. Epub 2015 Sep 4.

37.

Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation.

Gatault P, Bertrand D, Büchler M, Colosio C, Hurault de Ligny B, Weestel PF, Rerolle JP, Thierry A, Sayegh J, Moulin B, Snanoudj R, Rivalan J, Heng AE, Sautenet B, Lebranchu Y.

Transpl Int. 2016 Jan;29(1):41-50. doi: 10.1111/tri.12656.

38.

UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohort.

Dinic M, Ghisdal L, Racapé J, Thibaudin L, Gatault P, Essig M, Le Meur Y, Noël C, Touchard G, Merville P, Ajarchouh Z, Mariat C, Abramowicz M, Abramowicz D, Alamartine E.

BMC Nephrol. 2014 Aug 28;15:138. doi: 10.1186/1471-2369-15-138.

39.

Conversion to mTOR-inhibitor-based immunosuppression: which patients and when?

Gatault P, Lebranchu Y.

Transplant Res. 2013 Nov 20;2(Suppl 1):S3. doi: 10.1186/2047-1440-2-S1-S3. Epub 2013 Nov 20.

40.

Predicting 5-year risk of kidney transplant failure: a prediction instrument using data available at 1 year posttransplantation.

Shabir S, Halimi JM, Cherukuri A, Ball S, Ferro C, Lipkin G, Benavente D, Gatault P, Baker R, Kiberd B, Borrows R.

Am J Kidney Dis. 2014 Apr;63(4):643-51. doi: 10.1053/j.ajkd.2013.10.059. Epub 2013 Dec 31.

PMID:
24387794
41.

Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study.

Chaigne B, Gatault P, Darrouzain F, Barbet C, Degenne D, François M, Szymanski P, Rabot N, Golea G, Diot E, Maillot F, Lebranchu Y, Nivet H, Paintaud G, Halimi JM, Guillevin L, Büchler M.

Clin Exp Immunol. 2014 May;176(2):172-9. doi: 10.1111/cei.12246.

42.

Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation.

Longuet H, Sautenet B, Gatault P, Thibault G, Barbet C, Marliere JF, Halimi JM, Lebranchu Y, Baron C, Büchler M.

Transpl Int. 2014 Mar;27(3):271-9. doi: 10.1111/tri.12249. Epub 2013 Dec 27.

43.

Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch.

Gatault P, Jollet I, Paintaud G, Magdelaine C, Bridoux F, Lebranchu Y, Büchler M, Touchard G, Thierry A.

Hum Immunol. 2013 Dec;74(12):1616-8. doi: 10.1016/j.humimm.2013.08.278. Epub 2013 Aug 29. Erratum in: Hum Immunol. 2015 Mar;76(2-3):206. Philippe, Gatault [corrected to Gatault, Philippe]; Isabelle, Jollet [corrected to Jollet, Isabelle]; Gilles, Paintaud [corrected to Paintaud, Gilles]; Charlotte, Magdelaine [corrected to Magdelaine, Charlotte];Franck, Bridoux [corrected to Bridoux, Franck.

PMID:
23994588
44.

CMV infection in the donor and increased kidney graft loss: impact of full HLA-I mismatch and posttransplantation CD8(+) cell reduction.

Gatault P, Halimi JM, Forconi C, Thibault G, Barbet C, Mérieau E, Gaudy-Graffin C, Marlière JF, Goudeau A, Bruyère F, Lebranchu Y, Büchler M, Baron C.

Am J Transplant. 2013 Aug;13(8):2119-29. doi: 10.1111/ajt.12298. Epub 2013 Jun 3.

45.

Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial.

Büchler M, Longuet H, Lemoine R, Herr F, Gatault P, Thibault G, Ternant D, Foulon C, Pilorge B, Lemay D, Sung C, Halimi JM, Baron C, Lebranchu Y.

Transpl Immunol. 2013 Mar;28(2-3):120-6. doi: 10.1016/j.trim.2013.03.001. Epub 2013 Mar 16.

PMID:
23507258
46.

New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipients.

Benz-de Bretagne I, Le Guellec C, Halimi JM, Gatault P, Barbet C, Alnajjar A, Büchler M, Lebranchu Y, Andres CR, Vourcʼh P, Blasco H.

Ther Drug Monit. 2012 Jun;34(3):289-97. doi: 10.1097/FTD.0b013e31824a6534.

PMID:
22585184
47.

Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation.

Mutinelli-Szymanski P, Caille A, Tranquart F, Al-Najjar A, Büchler M, Barbet C, Marlière JF, Gatault P, Réault J, Boin C, Chatelet V, Laouad I, Nivet H, Lebranchu Y, Halimi JM.

Transpl Int. 2012 Apr;25(4):464-70. doi: 10.1111/j.1432-2277.2012.01445.x. Epub 2012 Feb 24.

48.

Doubling of serum creatinine in clinical trials, cost-effectiveness studies, and individual patients: adequate use in renal transplantation.

Gatault P, Al-Najjar A, Barbet C, Roland M, Laouad I, Buchler M, Marlière JF, Métais PE, Clément A, Nivet H, Lebranchu Y, Halimi JM.

Transplantation. 2011 Nov 15;92(9):1012-7. doi: 10.1097/TP.0b013e31823015e4.

PMID:
21941225
49.

Acute and chronic nephropathy induced by fluindione must be addressed.

Cam G, Kwetcheu AT, Vigneau C, Siohan P, Queffeulou G, Gatault P, Laruelle E, Crémault A, Le Cacheux P, Rioux-Leclercq N, Renaudineau E.

Nephrol Dial Transplant. 2012 Apr;27(4):1554-8. doi: 10.1093/ndt/gfr500. Epub 2011 Sep 19.

PMID:
21931126
50.

Mothers without HLA antibodies before transplantation have a low risk of alloimmunization post-transplantation.

Gatault P, Jollet I, Rabot N, Boulanger MD, Taupin JL, Barbet C, Baron C, Thierry A, Halimi JM, Lebranchu Y, Touchard G, Büchler M.

Tissue Antigens. 2011 Oct;78(4):241-8. doi: 10.1111/j.1399-0039.2011.01757.x.

PMID:
21929572

Supplemental Content

Loading ...
Support Center